Company / Total Assets
West Pharmaceutical Services Total Assets History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$4.3B
FY2025
5-year range
$3.3B / $4.3B
FY2021-FY2025
Trend
+17.2%
vs FY2024
Sector context
#65 of 161
Health Care
What the data says
At $4.3B, West Pharmaceutical Services's total assets ranks #65 of 161 in the Health Care sector. Improved from $3.8B to $4.3B over the past 2 years.
Based on SEC 10-K filings.
$4.3B in FY2025 with a 5-year CAGR of +8.9%.
Improved from $3.8B to $4.3B over the past 2 years.
Health Care sector context is included.
Total Assets over time
Growth rates
- 3-Year CAGR
- +5.7%
- 5-Year CAGR
- +8.9%
- 10-Year CAGR
- -
Sector benchmark
#65 of 161 in Health CareTop 40% of 161This company $4.3B Sector average $14.8B
▼
-71.1% below sector average
Key checks
Key Insights
- 5-year CAGR of +8.9%, indicating consistent growth.
- In FY2025, total assets increased 17.2% year-over-year.
- Ranks #65 out of 161 companies in the Health Care sector.
- Lowest total assets in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score 3.45 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $4.3B | +17.2% |
| FY2024 | $3.6B | -4.9% |
| FY2023 | $3.8B | +5.9% |
| FY2022 | $3.6B | +9.1% |
| FY2021 | $3.3B | +18.6% |
| FY2020 | $2.8B | +19.3% |
| FY2019 | $2.3B | +18.3% |
| FY2018 | $2.0B | +6.2% |
| FY2017 | $1.9B | +9.9% |
| FY2016 | $1.7B | +1.5% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026